BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25636120)

  • 1. Higher levels of knowledge reduce health care costs in patients with inflammatory bowel disease.
    Colombara F; Martinato M; Girardin G; Gregori D
    Inflamm Bowel Dis; 2015 Mar; 21(3):615-22. PubMed ID: 25636120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
    Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
    J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
    Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
    J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Crohn's and Colitis Knowledge Score: a test for measuring patient knowledge in inflammatory bowel disease.
    Eaden JA; Abrams K; Mayberry JF
    Am J Gastroenterol; 1999 Dec; 94(12):3560-6. PubMed ID: 10606319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-reported Health Care Utilization of Patients with Inflammatory Bowel Disease Correlates Perfectly with Medical Records.
    Severs M; Petersen RE; Siersema PD; Mangen MJ; Oldenburg B
    Inflamm Bowel Dis; 2016 Mar; 22(3):688-93. PubMed ID: 26835981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Worries and Concerns Information Side Effects?
    Berroa E; Fernández-Salazar L; Rodríguez McCullough N; Garrote Adrados JA
    Inflamm Bowel Dis; 2015 Sep; 21(9):E22. PubMed ID: 26218139
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Are Worries and Concerns Information Side Effects?
    Gregori D
    Inflamm Bowel Dis; 2015 Sep; 21(9):E23. PubMed ID: 26244651
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications.
    Kostić M; Djakovic L; Šujić R; Godman B; Janković SM
    Appl Health Econ Health Policy; 2017 Feb; 15(1):85-93. PubMed ID: 27587010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Initiation of Anti-TNF Therapy on the Subsequent Direct Health Care Costs of Inflammatory Bowel Disease.
    Targownik LE; Benchimol EI; Witt J; Bernstein CN; Singh H; Lix L; Tennakoon A; Zubieta AA; Coward S; Jones J; Kuenzig E; Murthy SK; Nguyen GC; Peña-Sánchez JN; Kaplan G
    Inflamm Bowel Dis; 2019 Sep; 25(10):1718-1728. PubMed ID: 31211836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs of inflammatory bowel disease in Germany.
    Stark R; König HH; Leidl R
    Pharmacoeconomics; 2006; 24(8):797-814. PubMed ID: 16898849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-health: Web-guided therapy and disease self-management in ulcerative colitis. Impact on disease outcome, quality of life and compliance.
    Elkjaer M
    Dan Med J; 2012 Jul; 59(7):B4478. PubMed ID: 22759851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
    Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
    J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost analysis and cost determinants in a European inflammatory bowel disease inception cohort with 10 years of follow-up evaluation.
    Odes S; Vardi H; Friger M; Wolters F; Russel MG; Riis L; Munkholm P; Politi P; Tsianos E; Clofent J; Vermeire S; Monteiro E; Mouzas I; Fornaciari G; Sijbrandij J; Limonard C; Van Zeijl G; O'morain C; Moum B; Vatn M; Stockbrugger R;
    Gastroenterology; 2006 Sep; 131(3):719-28. PubMed ID: 16952541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
    Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
    J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Has patient knowledge of Inflammatory Bowel Disease improved since 1999?
    Wardle RA; Mayberry JF
    Acta Gastroenterol Belg; 2015 Dec; 78(4):381-5. PubMed ID: 26712047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does the hospital cost of care differ for inflammatory bowel disease patients with or without gastrointestinal infections? A case-control study].
    Schmidt C; Köhler F; Kräplin T; Hartmann M; Lerch MM; Stallmach A
    Z Gastroenterol; 2014 Jul; 52(7):643-8. PubMed ID: 25026005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of disease-related knowledge and possible factors associated with the knowledge level among Chilean patients with inflammatory bowel disease.
    Simian D; Flores L; Quera R; Kronberg U; Ibáñez P; Figueroa C; Lubascher J
    J Clin Nurs; 2017 Jun; 26(11-12):1508-1515. PubMed ID: 27322103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Costs and resource utilization for diagnosis and treatment during the initial year in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom Study.
    Burisch J; Vardi H; Pedersen N; Brinar M; Cukovic-Cavka S; Kaimakliotis I; Duricova D; Bortlik M; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Krabbe S; Andersen V; Dahlerup JF; Kjeldsen J; Salupere R; Olsen J; Nielsen KR; Manninen P; Collin P; Katsanos KH; Tsianos EV; Ladefoged K; Lakatos L; Bailey Y; OʼMorain C; Schwartz D; Lupinacci G; De Padova A; Jonaitis L; Kupcinskas L; Turcan S; Barros L; Magro F; Lazar D; Goldis A; Nikulina I; Belousova E; Fernandez A; Pineda JR; Almer S; Halfvarson J; Tsai HH; Sebastian S; Friger M; Greenberg D; Lakatos PL; Langholz E; Odes S; Munkholm P;
    Inflamm Bowel Dis; 2015 Jan; 21(1):121-31. PubMed ID: 25437816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.